Davis's Drug Guide
infigratinib
General
Genetic Implications:
**Off Market Drug**
This medication is no longer available in the United States. Information provided here is for reference purposes only.
Pronunciation:
in-fig-ra-ti-nib
Trade Name(s)
- Truseltiq
Ther. Class.
Pharm. Class.
kinase inhibitors
fibroblast growth factor receptor inhibitor
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Infigratinib." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110943/4/infigratinib.
Vallerand AHA, Sanoski CAC, Quiring CC. Infigratinib. Davis's Drug Guide. F.A. Davis Company; 2023. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110943/4/infigratinib. Accessed May 1, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Infigratinib. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110943/4/infigratinib
Vallerand AHA, Sanoski CAC, Quiring CC. Infigratinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 May 01]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110943/4/infigratinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - infigratinib
ID - 110943
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/110943/4/infigratinib
PB - F.A. Davis Company
ET - 18
DB - Emergency Central
DP - Unbound Medicine
ER -
